Meta Software Update Brings Hearing Assistance to Ray-Ban Smart Glasses

Meta is adding a hearing assistance feature to its Ray-Ban smart glasses through a software update, according to announcements from the company. The feature — described as real-time speech enhancement — is designed to help people with mild to moderate hearing difficulty follow conversations more clearly, without requiring a dedicated hearing aid.

The development is notable because it brings hearing accessibility into a mainstream consumer device that retails for around $329, well below the cost of even entry-level prescription hearing aids.

Editorial note: This article is based on Meta's announced feature rollout. Independent clinical validation of the feature's performance has not yet been published. Consumers with diagnosed hearing loss should consult a licensed audiologist before relying on any non-medical device for hearing support.

What the feature does

The software update enables the Ray-Ban smart glasses' built-in microphones — originally designed for calls and voice commands — to function as directional hearing enhancement tools. According to Meta's description, the feature can:

• Amplify nearby speech while reducing background noise
• Focus on a speaker in front of the wearer using directional microphone processing
• Stream enhanced audio directly to the wearer's ears through the glasses' open-ear speakers

The glasses do not sit in or on the ear canal the way traditional hearing aids do. Audio is delivered through small speakers positioned near the ears, which means sound quality and isolation differ from conventional hearing aid designs.

The $329 price point in context

The cost comparison with hearing aids is significant. A pair of prescription hearing aids from a private audiologist typically costs between $3,000 and $7,000. Even FDA-regulated over-the-counter hearing aids — designed for adults with mild to moderate hearing loss — generally range from $200 to $1,500 per pair.

At $329 for the full Ray-Ban smart glasses package, the hearing assistance feature arrives as part of a device consumers may already own or consider for other reasons, such as photography, calls, and music. That changes the effective cost calculation for someone already interested in the glasses.

However, price alone does not determine clinical appropriateness. OTC hearing aids are regulated by the FDA and must meet specific performance and labeling standards. Smart glasses with hearing enhancement software are consumer electronics, not medical devices, and are not subject to the same regulatory framework.

Who this may help — and who it won't

The feature appears best suited for people who:

• Have mild difficulty following conversations, particularly in noisy environments
• Are not yet ready to pursue a formal hearing evaluation or hearing aid fitting
• Already own or are considering Ray-Ban smart glasses for other uses
• Want a discreet, socially normalized form factor — glasses carry less stigma than visible hearing aids for some users

The feature is unlikely to be sufficient for people with:

• Moderate to severe hearing loss requiring calibrated amplification across specific frequency ranges
• Audiogram-confirmed hearing loss that falls outside the mild category
• Tinnitus as a primary concern, which typically requires dedicated masking or sound therapy features
• Conditions requiring medical evaluation, such as sudden hearing loss or asymmetric loss

Audiologists have consistently noted that self-assessed hearing difficulty often underestimates actual loss. People who notice consistent difficulty following speech — in any setting — are encouraged to get a formal hearing test before deciding whether a consumer device addresses their needs.

What it means for the hearing aid industry

The entry of a major consumer technology platform into hearing assistance is a development the hearing aid industry has anticipated since the FDA's 2022 OTC rule change opened the market to non-traditional players.

Sony, Jabra (a subsidiary of GN Audio), and Bose have all introduced OTC hearing aids since 2022. Apple has added hearing health features to AirPods Pro, including a clinical-grade hearing test and a hearing aid mode cleared by the FDA in 2024. Meta's move follows a similar logic: leverage existing hardware and a large consumer install base to address an underserved health need.

The distinction between Apple's approach and Meta's is regulatory. Apple's AirPods Pro hearing aid mode received FDA clearance as a medical device. Meta's Ray-Ban feature, as currently described, is a software enhancement to a consumer electronics product — not an FDA-cleared hearing aid.

That distinction matters for consumers making decisions about their hearing health. FDA clearance requires the manufacturer to demonstrate that the device is safe and effective for its intended use. Consumer electronics features do not carry that assurance.

What to do if you're considering this

If you have noticed difficulty hearing conversations and are curious about whether Meta's smart glasses feature could help, a reasonable sequence is:

1. Get a hearing test first. A licensed audiologist or hearing instrument specialist can give you an audiogram that shows exactly what frequencies are affected and how severe your loss is. This takes about an hour and is often covered by insurance.

2. Understand your loss category. If your audiogram shows mild loss, consumer hearing enhancement tools — including smart glasses features and FDA-regulated OTC aids — may be appropriate options to explore. If your loss is moderate or greater, a prescription device and professional fitting are likely to serve you better.

3. Compare the options. A $329 pair of smart glasses with hearing enhancement is a different product from a $500 pair of FDA-regulated OTC hearing aids, which is itself a different product from a $3,000 pair of prescription hearing aids fitted by an audiologist. Each tier offers different performance, customization, and clinical oversight.

4. Don't delay care. Research consistently shows that people wait an average of seven years between noticing hearing difficulty and seeking treatment. Untreated hearing loss is associated with increased risk of cognitive decline, social isolation, and depression. A consumer device that lowers the barrier to addressing hearing difficulty is a net positive — as long as it doesn't substitute for appropriate care when that care is needed.

---

Want to understand your hearing before exploring any device? Take our free online hearing screening to get a baseline sense of where you stand — and what questions to bring to an audiologist.